Medscape

FDA Approves HIV-1 Treatment Ibalizumab for 30-Second IV Push

The Food and Drug Administration (FDA) has approved the HIV-1 medication ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for administration by intravenous push. Ibalizumab-uiyk, a long-acting ...
Monthly Prescribing Reference

New Trogarzo Administration Method Cuts Maintenance Dose Time for HIV Patients

The approval was based on data from the phase 3 TMB-302 trial that evaluated Trogarzo 800mg administered via IV push once every 2 weeks. The Food and Drug Administration (FDA) has approved Trogarzo ® ...
Nasdaq

Theratechnologies Announces FDA Approval of Trogarzo® 90-Second Intravenous (IV) Push Loading Dose

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, ...
KPBS

A Hospital Charged More Than $700 For Each Push Of Medicine Through Her IV

Claire Lang-Ree was in a lab coat taking a college chemistry class remotely in the kitchen of her Colorado Springs, Colo., home when a profound pain twisted into her lower abdomen. She called her mom, ...
Business Insider

Heron Announces FDA Approval of Supplemental New Drug Application to Expand CINVANTI® Label for IV Push

SAN DIEGO, Feb. 26, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class ...